Founded with a mission to address unmet nutritional needs, Alcresta develops and commercializes innovative, enzyme-based nutritional products. The company's core focus is on improving nutrition and managing disease for infants, aging adults, and individuals with acute or chronic health conditions. Alcresta's proprietary, research-driven approach leverages expertise in both adult and pediatric nutrition, as well as protein manufacturing, to create point-of-care solutions designed for enteral feeding.
Alcresta has garnered attention for its impactful contributions to the field of medical nutrition, particularly for patients with serious medical conditions who require enteral feeding. The company's enzyme-based products are designed to aid in the digestion and absorption of essential nutrients, thereby enhancing growth, immunity, and overall organ function. Notable investors and affiliated experts in the fields of biotechnology and healthcare have supported Alcresta's mission, contributing to its reputation as a leader in enzyme-based nutritional solutions.
